Executive Director, Strategy & Commercial Development, Neuroscience

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits.

This is work that transforms the lives of patients, and the careers of those who do it.

Position Summary

The Executive Director, Neurodegeneration Strategy and Commercial Development will serve as the commercial leader accountable for maximizing the value of BMS's rapidly expanding neurodegeneration portfolio, spanning Alzheimer's disease, Parkinson's disease/Dementia with Lewy Bodies (DLB), and other neurodegenerative conditions. This position is responsible for defining and executing integrated strategy as well as managing a diverse pipeline of early- and mid-stage neurodegeneration assets, while also owning Market Development, building BMS’s presence in these new areas.

This role provides commercial leadership across the neurodegeneration pipeline from Discovery through Phase 3. (S) he will partner closely with Development, Medical, Regulatory, CMC, Commercial, and Project Leadership to optimize development strategy, brand development, and market preparation for each asset, and will work closely with key markets, Business Insights & Analytics (BI&A), and Value, Access & Pricing (VAP) to ensure appropriate commercial input into product development decisions.

(S) he will optimize the value of the neurodegeneration portfolio by identifying areas for growth, seeking opportunities within and beyond the organization to add value to long-term plans. This position will represent key products at the Global Program Team level and will be responsible for overall commercial direction for the neurodegeneration area.

In addition to pipeline and development strategy, this person will own Market– establishing strategic platforms to prepare the market for launch, shaping BMS's biomarker and diagnosis strategy, and building relationships with patient advocacy organizations, medical societies, and thought leaders. The Executive Director will lead the organization's efforts to shape BMS's presence in neurodegeneration, including defining commercialization strategies, understanding customer and market dynamics, and preparing for launches in these high-value emerging therapeutic spaces.

The Executive Director will develop the long-range plan for neurodegeneration assets and partner to build out corporate presence in support of relevant products in development, guiding products through successful transition at key stage gates and representing key products to Executive Management.

The leader must be able to operate in a fast-paced organization, with high expectations and accountability on quality of deliverables and the ability to create an energizing, inclusive culture. Demonstrated ability to create strategy and to lead and influence across functions, including Clinical, Regulatory, MAx, Medical, BI&A, and cross-functional Commercial partners, is required. Leads Commercial Teams and represents commercial interests on Global Program Teams.

Domestic and International travel required (~20%).

• Leads worldwide brand planning and long-range forecasting across the neurodegeneration pipeline, including assets from Discovery through Phase 2b/3 in Alzheimer’s, Parkinson’s, and other neurodegenerative conditions.

• Owns Neurodegeneration Market Development, including biomarker and diagnosis strategy, patient identification pathways, and preparation…